初级保健中抑郁症治疗依从性:一项随机临床试验
这项在纽约和安娜堡初级保健诊所开展的两中心随机临床试验,纳入231例≥55岁新启动抗抑郁药治疗的中老年抑郁患者,评估治疗启动与参与项目(TIP)对早期依从性的效果。TIP组在6周和12周依从率显著高于常规治疗组,且抑郁症状更早减轻。
要点
- TIP干预可显著改善中老年抑郁患者早期抗抑郁药依从性。
- TIP组在6周和12周均依从的比值比是常规组的3.27倍。
- 早期依从性改善与抑郁症状更早减轻相关。
核心结论
- TIP项目是改善药物治疗早期依从性的有效干预措施。
- 依从性改善可促进抑郁症状的改善。
研究设计与样本
- 两中心随机临床有效性研究,2011年1月至2014年12月在纽约和安娜堡的初级保健诊所开展。
- 纳入231例≥55岁、由初级保健医生新启动抗抑郁药治疗且在处方后10天内招募的中老年患者,无显著认知障碍。
- 随机分配至TIP干预组(n=115)或常规治疗组(n=116),采用意向性分析。
主要发现
- TIP组在6周时依从的比值比为5.54(95% CI,2.57至11.96;χ²₁=19.05;P<.001)。
- TIP组在6周和12周均依从的比值比为3.27(95% CI,1.73至6.17;χ²₁=13.34;P<.001)。
- TIP组抑郁症状更早减轻24.9%(95% CI,13.9至35.9;t₃₃₇=4.46;校正P<.001)。
- 两组中6周和12周依从≥80%者抑郁症状从基线改善多15%(95% CI,-0.2至-30;t₃₆₉=1.93;P=.051)。
关键数值与推荐
- 早期充分依从定义为6周和12周时服用≥80%的处方剂量,采用简易用药问卷自报。
临床怎么用
- 在初级保健中,对≥55岁新启动抗抑郁药的中老年抑郁患者可提供TIP干预以改善早期依从性。
- TIP干预包括在处方后6周内进行3次30分钟接触,识别并解决依从性障碍(如病耻感、误解和对治疗的恐惧),制定个性化依从策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Nonadherence to antidepressant medication is common and leads to poor outcomes. Early nonadherence is especially problematic. OBJECTIVE: To test the effectiveness of a psychosocial intervention to improve early adherence among older patients whose primary care physician newly initiated an antidepressant for depression. DESIGN, SETTING, AND PARTICIPANTS: The Treatment Initiation and Participation Program (TIP) was offered in a 2-site randomized clinical effectiveness study between January 2011 and December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan. Analyses began in February 2016. All participants were middle-aged and older adults (aged ≥55 years) who received newly initiated depression treatment by their primary care physician and recruited within 10 days of their prescription. Analyses were intention-to-treat. INTERVENTIONS: Participants were randomly assigned to the intervention (TIP) or treatment as usual. Participants in the TIP group identified and addressed barriers to adherence, including stigma, misconceptions, and fears about treatment, before developing a personalized adherence strategy. The Treatment Initiation and Participation Program was delivered in three 30-minute contacts scheduled during a 6-week period just after the antidepressant was prescribed. MAIN OUTCOMES AND MEASURES: The primary outcome was self-reported adherence on the Brief Medication Questionnaire, with adequate early adherence defined as taking 80% or more of the prescribed doses at 6 and 12 weeks. The secondary outcome was depression severity. RESULTS: In total, 231 middle-aged and older adults (167 women [72.3%] and 64 men [27.7%]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115) or treatment as usual (n = 116). Participants had a mean (SD) age of 67.3 (8.4) years. Participants in the TIP group were 5 times more likely to be adherent at 6 weeks (odds ratio, 5.54; 95% CI, 2.57 to 11.96; χ21 = 19.05; P < .001) and 3 times more likely to be adherent at both 6 and 12 weeks (odds ratio, 3.27; 95% CI, 1.73 to 6.17; χ21 = 13.34; P < .001). Participants in the TIP group showed a significant earlier reduction (24.9%) in depressive symptoms (95% CI, 13.9 to 35.9; t337 = 4.46; adjusted P < .001). In both groups, participants who were 80% adherent at weeks 6 and 12 had a 15% greater improvement in depressive symptoms from baseline over the course of treatment (95% CI, -0.2 to -30; t369 = 1.93; P = .051). CONCLUSIONS AND RELEVANCE: The Treatment Initiation and Participation Program is an effective intervention to improve early adherence to pharmacotherapy. Improved adherence can promote improvement in depression. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01301859.
引用
- Sirey JA, Banerjee S, Marino P, et al. Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017. PMID: 28973066. doi:10.1001/jamapsychiatry.2017.3047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。